AGP Limited (PSX:AGP)

Market Cap	58.27B
Revenue (ttm)	25.03B
Net Income (ttm)	2.67B
Shares Out	280.00M
EPS (ttm)	9.53
PE Ratio	21.83
Forward PE	15.65
Dividend	4.00 (1.92%)
Ex-Dividend Date	n/a

Volume	595,025
Average Volume	345,058
Open	207.00
Previous Close	209.58
Day's Range	204.50 - 211.44
52-Week Range	78.30 - 214.90
Beta	0.41
RSI	66.71
Earnings Date	Apr 25, 2025

About AGP Limited

AGP Limited manufactures, sells, wholesales, distributes, exports, imports, markets, deals in pharmaceutical and healthcare products in Pakistan and Afghanistan. The company offers products in the areas of aminoglycosides, angiotensin II antagonist, anti-epileptics, anti-gout, anti-infective antidiarrheal, anti-inflammatory enzyme, antidiarrheal microorganisms, antifibrinolytic, antihistamines systemic, antileuk anti-ashtm sys, antineoplastic agent, anti-obesity, antirheumatic non-steroid, antispasmodic and anticholinergic plain, atypical antip...

• Industry: Pharmaceuticals
• Sector: Healthcare
• Founded: 1989
• Employees: 2,143
• Stock Exchange: Pakistan Stock Exchange
• Ticker Symbol: AGP

Financial Performance

In 2024, AGP Limited's revenue was 25.03 billion, an increase of 33.56% compared to the previous year's 18.74 billion. Earnings were 2.67 billion, an increase of 70.58%.